98%
921
2 minutes
20
Post-prostatectomy urinary incontinence (PPUI) is an important issue in the urological practice and imposes a negative effect on quality of life (QoL). Despite recent technological advances, PPUI remains a common complication and the artificial urinary sphincter (AUS) is regarded as the most effective long-term surgical treatment for moderate-to-severe stress urinary incontinence. Success rates for AUS as defined by a continence status of zero to one pad per day range from 59% to 90%. One potential downside of the AUS is the need for periodic revisions in a number of patients. Revision and explantation rates due to mechanical failure, urethral atrophy, infection and erosion vary considerably among studies with reports of 8-45% and 7-17%, respectively. These complications can be classified into different categories, including recurrent or refractory incontinence, erosion and/or infection, and other complications. This review article aims to describe the main AUS-related complications and their management strategies. Diagnostic work-up strategies are explored to facilitate timely identification and management of these complications. Additionally, emerging technologies and future directions in AUS development are discussed, highlighting potential advancements to mitigate complications and enhance device performance. This review consolidates current knowledge and provides insights for clinicians to manage the complexities associated with AUS therapy effectively.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11399024 | PMC |
http://dx.doi.org/10.21037/tau-22-830 | DOI Listing |
Clin Infect Dis
September 2025
VA Maryland Health Care System, Baltimore, Maryland, USA.
A retrospective cohort study compared generative artificial intelligence (GenAI) vs. infection control expert for catheter-associated urinary tract infection (CAUTI) detection. Sensitivity was 95.
View Article and Find Full Text PDFAdv Healthc Mater
September 2025
Department of Biomedical Engineering, University of Houston, Houston, TX, 77204, USA.
Neurogenic bladder and lower urinary tract (LUT) dysfunctions encompass a wide variety of urinary disorders resulting from nervous system impairments. Unfortunately, conventional treatments are still limited and can have significant complication rates, especially when stent implantations or other surgical procedures are involved. Therefore, there is a critical need to develop novel therapeutic strategies and pharmacological approaches to address these challenging urological conditions.
View Article and Find Full Text PDFMol Biol Rep
September 2025
Department of Physiology, Faculty of Medicine, Ataturk University, Erzurum, Turkey.
Aim: Ischemia-reperfusion (IR) injury-induced renal failure is a major cause of death and morbidity. Unfortunately, there is currently no proven protective therapy. The aim of the study is to investigate the protective effect of D-carvone against the renal ischemia-reperfusion (RIR) injury.
View Article and Find Full Text PDFNeurourol Urodyn
September 2025
Department of Urology, School of Medicine, Division of Pediatric Urology, Marmara University, Istanbul, Turkey.
Aim: Uroflowmetry (UF) is one of the most commonly used noninvasive tests in the evaluation of children with lower urinary tract symptoms (LUTS). However, studies have highlighted a weak agreement among experts interpreting voiding patterns. This study aims to assess the impact of Machine Learning (ML) models, which have become increasingly prevalent in medicine, on the interpretation of voiding patterns.
View Article and Find Full Text PDFBiosens Bioelectron
August 2025
Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine Vision and Brain Health), Wenzhou Institute, University of Chinese Academy of Sciences, Wenzhou, Zhejiang, 325000, China; Beijing National Laboratory for Condensed Matter Physics, Institute of Physics, Chinese Academy of Sciences, Beijing, 1
The escalating threat of antimicrobial resistance is exacerbated by delayed diagnostics and improper antibiotics use, underscoring an urgent demand for rapid, versatile AST tools to support evidence-based prescribing. In this study, we present an innovative, generalizable phenotypic AST approach by quantifying bacterial gDNA copy number variations (CNVs) following 0.5-h-brief culturing with antibiotic exposure, termed spatially encapsulated emulsions (SEE)-phAST.
View Article and Find Full Text PDF